• 最新新闻
  • 高端访谈
  • 学术活动
  • 精英团队
  • 国际前沿
  • 精品文章
    • Quibim Unveils Four On...
      Quibim @ ASCO 2025: AI imaging breakthroughs in immunotherapy prediction (CD8 PET/CT), tumor quantification (MRI), and non-invasive PD-L1 assessment (CT), plus DIPCAN multi-omics integration. 了解更多
    • ConcertAI’s TeraRecon ...
      Cloud-based, innovative, AI-powered technologies enable the streamlined delivery of leading clinical services and scaled operations in advanced imaging 了解更多